High-dose versus standard-dose intermittent meropenem in critically ill patients: An observational cohort study
Felix Bergmann, Marlene Prager, Lena Pracher, Katarina Kumpf, Markus Zeitlinger, Anselm Jorda
Springer Nature ·
2026-01-01
· DOI 10.1016/j.aicoj.2025.100022
The publisher did not provide an abstract — full text is available via the link below.
Felix Bergmann, Marlene Prager, Lena Pracher, Katarina Kumpf, Markus Zeitlinger, Anselm Jorda. High-dose versus standard-dose intermittent meropenem in critically ill patients: An observational cohort study. // Annals of Intensive Care. – 2026. – DOI: 10.1016/j.aicoj.2025.100022. – URL: https://doi.org/10.1016/j.aicoj.2025.100022
Felix Bergmann, Marlene Prager, Lena Pracher, Katarina Kumpf, Markus Zeitlinger, & Anselm Jorda (2026). High-dose versus standard-dose intermittent meropenem in critically ill patients: An observational cohort study. Annals of Intensive Care. https://doi.org/10.1016/j.aicoj.2025.100022
Felix Bergmann, et al. “High-dose versus standard-dose intermittent meropenem in critically ill patients: An observational cohort study.” Annals of Intensive Care, 2026. doi:10.1016/j.aicoj.2025.100022.
@article{Bergmann2026,
title = {High-dose versus standard-dose intermittent meropenem in critically ill patients: An observational cohort study},
author = {Bergmann, Felix and Prager, Marlene and Pracher, Lena and Kumpf, Katarina and Zeitlinger, Markus and Jorda, Anselm},
journal = {Annals of Intensive Care},
year = {2026},
doi = {10.1016/j.aicoj.2025.100022},
url = {https://doi.org/10.1016/j.aicoj.2025.100022}
}